Redmile as of March 31, 2015
Portfolio Holdings for Redmile
Redmile holds 54 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 8.7 | $97M | 13M | 7.37 | |
| Clovis Oncology | 6.0 | $67M | 901k | 74.23 | |
| Amicus Therapeutics (FOLD) | 5.7 | $64M | 5.8M | 10.88 | |
| Valeant Pharmaceuticals Int | 4.8 | $53M | 269k | 198.62 | |
| Teva Pharmaceutical Industries (TEVA) | 4.8 | $53M | 854k | 62.30 | |
| Endo International | 4.5 | $50M | 560k | 89.70 | |
| Auspex Pharmaceuticals | 3.8 | $42M | 418k | 100.27 | |
| Biogen Idec (BIIB) | 3.7 | $41M | 98k | 422.24 | |
| Seattle Genetics | 3.3 | $37M | 1.1M | 35.35 | |
| Alere | 2.9 | $33M | 664k | 48.90 | |
| Chimerix (CMRX) | 2.9 | $32M | 845k | 37.69 | |
| Insmed (INSM) | 2.6 | $29M | 1.4M | 20.80 | |
| Receptos | 2.4 | $26M | 159k | 164.89 | |
| D Fluidigm Corp Del (LAB) | 2.1 | $24M | 562k | 42.10 | |
| Aetna | 2.0 | $23M | 212k | 106.53 | |
| DaVita (DVA) | 1.9 | $22M | 266k | 81.28 | |
| Healthways | 1.9 | $21M | 1.1M | 19.70 | |
| Ultragenyx Pharmaceutical (RARE) | 1.9 | $21M | 333k | 62.09 | |
| Oxford Immunotec Global | 1.8 | $20M | 1.4M | 14.08 | |
| Civitas Solutions | 1.6 | $18M | 880k | 20.94 | |
| Castlight Health | 1.6 | $18M | 2.3M | 7.76 | |
| Model N (MODN) | 1.6 | $18M | 1.5M | 11.96 | |
| Jazz Pharmaceuticals (JAZZ) | 1.6 | $17M | 100k | 172.79 | |
| Zs Pharma | 1.5 | $17M | 406k | 42.08 | |
| Avalanche Biotechnologies In | 1.5 | $17M | 421k | 40.52 | |
| VCA Antech | 1.5 | $17M | 308k | 54.82 | |
| Trivascular Technologies | 1.5 | $17M | 1.6M | 10.49 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 1.5 | $16M | 751k | 21.88 | |
| Health Net | 1.5 | $16M | 270k | 60.49 | |
| Intra Cellular Therapies (ITCI) | 1.4 | $16M | 669k | 23.88 | |
| Globus Med Inc cl a (GMED) | 1.4 | $15M | 612k | 25.24 | |
| Celldex Therapeutics | 1.4 | $15M | 547k | 27.87 | |
| Accuray Incorporated (ARAY) | 1.3 | $14M | 1.5M | 9.30 | |
| Tekmira Pharmaceuticals Corporation | 1.1 | $12M | 700k | 17.46 | |
| Kythera Biopharmaceuticals I | 1.0 | $11M | 225k | 50.15 | |
| Nanostring Technologies (NSTGQ) | 1.0 | $11M | 1.1M | 10.19 | |
| Atara Biotherapeutics | 1.0 | $11M | 265k | 41.57 | |
| Invitae (NVTAQ) | 1.0 | $11M | 785k | 13.94 | |
| Gw Pharmaceuticals Plc ads | 1.0 | $11M | 119k | 91.13 | |
| Genocea Biosciences | 0.8 | $9.5M | 797k | 11.86 | |
| Bellicum Pharma | 0.8 | $9.3M | 445k | 20.85 | |
| NuVasive | 0.8 | $8.5M | 185k | 45.99 | |
| Cerus Corporation (CERS) | 0.6 | $6.9M | 1.6M | 4.17 | |
| BioScrip | 0.6 | $6.1M | 1.4M | 4.43 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.5 | $5.0M | 4.0M | 1.26 | |
| Flexion Therapeutics | 0.4 | $4.3M | 190k | 22.52 | |
| Achaogen | 0.3 | $3.9M | 398k | 9.76 | |
| Otonomy | 0.2 | $2.8M | 79k | 35.35 | |
| Eleven Biotherapeutics | 0.2 | $2.1M | 240k | 8.92 | |
| iShares Dow Jones US Health Care (IHF) | 0.1 | $1.1M | 8.6k | 133.04 | |
| PowerShares QQQ Trust, Series 1 | 0.0 | $454k | 4.3k | 105.58 | |
| Market Vectors Etf Tr pharmaceutical | 0.0 | $457k | 6.5k | 70.31 | |
| Alexion Pharmaceuticals | 0.0 | $241k | 1.4k | 173.38 | |
| Chemocentryx | 0.0 | $132k | 18k | 7.54 |
